TY - JOUR
T1 - Suboptimal reporting of randomized controlled trials on non-pharmacological therapies in Chinese medicine
AU - Zhang, Xuan
AU - Li, Han
AU - Tan, Hanzhi
AU - Wang, Nana
AU - Cheng, Chung Wah
AU - Wang, Juan
AU - Shi, Dongni
AU - Zhang, Lin
AU - Liu, Yumeng
AU - Wang, Yao
AU - Luo, Shufeng
AU - Lin, Yaxin
AU - Hu, Lihan
AU - Zhang, Xuanqi
AU - Li, Ji
AU - Han, Fei
AU - Wang, Ping
AU - Lu, Aiping
AU - Bian, Zhaoxiang
N1 - The authors thank all the financial supports from Chinese Medicine Development Fund (Nos. 20B2/027A and 23B2-027A_R1), Hong Kong; Center for Evidence Based Traditional Chinese Medicine (CCEBTM, No. 2020YJSZX-5); National Natural Science Foundation of China (No. 81704198); Donation Funding of Vincent V.C. Woo Chinese Medicine Clinical Research Institute; and Health@InnoHK Initiative Fund of the Hong Kong Special Administrative Region Government (No. ITC RC/IHK/4/7). The funders had no role in the design of study, in the collection, analysis, and interpretation of data, nor in the writing of the manuscript.
PY - 2024/10
Y1 - 2024/10
N2 - With the successive release of the CONSORT extensions for acupuncture,
moxibustion, cupping, and Tuina/massage, this review aims to assess the
reporting characteristics and quality of randomized controlled trials
(RCTs) based on these specific guidelines. A comprehensive review was
conducted by searching multiple databases, including Embase, Ovid
MEDLINE(R), All EBM Reviews, AMED, CNKI, VIP Chinese Medical Journal
Database, and Wanfang Data, for publications from January 1 to December
31, 2022. Two reviewers independently evaluated the eligibility of the
records, extracted predetermined information, and assessed the reporting
based on the STRICTA, STRICTOM, STRICTOC, and STRICTOTM checklists.
Among the included 387 studies (acupuncture, 213; Tuina/massage, 85;
moxibustion, 73; cupping, 16), the overall reporting compliance averaged
56.0%, with acupuncture leading at 62.6%, followed by cupping (60.2%),
moxibustion (53.1%), and Tuina/massage (47.9%). About half of the
evaluated items showed poor reporting (compliance rate < 65%).
Notably, international journals demonstrated significantly higher
reporting quality than Chinese journals (P < 0.05). Although
acupuncture trials had relatively higher compliance rates, deficiencies
persist in reporting non-pharmacological therapies of Chinese medicine,
particularly in areas like treatment environment details and provider
background information.
AB - With the successive release of the CONSORT extensions for acupuncture,
moxibustion, cupping, and Tuina/massage, this review aims to assess the
reporting characteristics and quality of randomized controlled trials
(RCTs) based on these specific guidelines. A comprehensive review was
conducted by searching multiple databases, including Embase, Ovid
MEDLINE(R), All EBM Reviews, AMED, CNKI, VIP Chinese Medical Journal
Database, and Wanfang Data, for publications from January 1 to December
31, 2022. Two reviewers independently evaluated the eligibility of the
records, extracted predetermined information, and assessed the reporting
based on the STRICTA, STRICTOM, STRICTOC, and STRICTOTM checklists.
Among the included 387 studies (acupuncture, 213; Tuina/massage, 85;
moxibustion, 73; cupping, 16), the overall reporting compliance averaged
56.0%, with acupuncture leading at 62.6%, followed by cupping (60.2%),
moxibustion (53.1%), and Tuina/massage (47.9%). About half of the
evaluated items showed poor reporting (compliance rate < 65%).
Notably, international journals demonstrated significantly higher
reporting quality than Chinese journals (P < 0.05). Although
acupuncture trials had relatively higher compliance rates, deficiencies
persist in reporting non-pharmacological therapies of Chinese medicine,
particularly in areas like treatment environment details and provider
background information.
KW - CONSOR
KW - Chinese medicine
KW - Reporting guideline
KW - STRICTA
KW - STRICTOM
KW - STRICTOC
KW - STRICTOTM
UR - http://www.scopus.com/inward/record.url?scp=85201019979&partnerID=8YFLogxK
U2 - 10.1007/s11684-024-1084-4
DO - 10.1007/s11684-024-1084-4
M3 - Journal article
SN - 2095-0217
VL - 18
SP - 798
EP - 813
JO - Frontiers of Medicine
JF - Frontiers of Medicine
IS - 5
ER -